NCT06497517View on ClinicalTrials.gov

A Study to Investigate the Effect of Food on Camlipixant Concentrations in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

August 22, 2024

Study Completion Date

August 26, 2024

Conditions
Cough
Interventions
DRUG

GSK5464714- Camlipixant

GSK5464714- Camlipixant will be administered

Trial Locations (1)

78744

GSK Investigational Site, Austin

All Listed Sponsors
lead

Bellus Health Inc. - a GSK company

INDUSTRY

NCT06497517 - A Study to Investigate the Effect of Food on Camlipixant Concentrations in Healthy Participants | Biotech Hunter | Biotech Hunter